Yemchenko, Ya. O.Shynkevych, V. I.Ishcheikin, K. Ye.Kaidashev, I. P.Ємченко, Яна ОлександрівнаШинкевич, Вікторія ІгорівнаІщейкін, Костянтин ЄвгеновичКайдашев, Ігор Петрович2020-05-142020-05-142020PPAR-Gamma agonist pioglitazone reduced CD68+ but not CD163+ macrophage dermal infiltration in obese psoriatic patients / Ya. O. Yemchenko, V. I. Shynkevych, K. Ye. Ishcheikin, I. P. Kaidashev // Hindawi. – 2020. – С. 1–6. – Режим доступа: https://doi.org/10.1155/2020/4548012ID 4548012https://repository.pdmu.edu.ua/handle/123456789/12727Macrophages are of great importance in the development of obesity and psoriasis. Signaling via PPAR-γ in certain macrophage populations is associated with M2-like features and anti-inflammatory profile. In this research, we evaluated the anti-inflammatory action of pioglitazone by the immunohistochemical study of M1 and M2 macrophages in psoriasis-affected skin in obese patients.enpsoriasismacrophagesCD68+Article